PPARA and metabolic disease: A report demonstrated that Z-551, a PPARα agonist ameliorates high-fat diet-induced obesity and metabolic disorders in mice, and one of the mechanisms by which it exerts its effect is by reducing ATM that ultimately suppresses AT inflammation [160].